73 related articles for article (PubMed ID: 6257319)
1. Neurotoxicity with desmethylmisonidazole.
Dische S; Saunders MI; Stratford MR
Br J Radiol; 1981 Feb; 54(638):156-7. PubMed ID: 6257319
[No Abstract] [Full Text] [Related]
2. The neurotoxicity of misonidazole: pooling of data from five centres.
Disch S; Saunders MI; Anderson P; Urtasun RC; Karcher KH; Kogelnik HD; Bleehen N; Phillips TL; Wasserman TH
Br J Radiol; 1978 Dec; 51(612):1023-4. PubMed ID: 216455
[No Abstract] [Full Text] [Related]
3. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM
Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
[No Abstract] [Full Text] [Related]
4. Plasma concentration of misonidazole and peripheral neuropathy.
Marten TR
Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
[No Abstract] [Full Text] [Related]
5. Neurotoxicity of Adriamycin and misonidazole in the mouse.
Boegman RJ; Scarth B; Dragovic L; Robertson DM
Exp Neurol; 1985 Jan; 87(1):1-8. PubMed ID: 2981696
[TBL] [Abstract][Full Text] [Related]
6. Misonidazole neuropathy.
Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
[TBL] [Abstract][Full Text] [Related]
7. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Schwade JG; Makuch RW; Strong JM; Glatstein E
Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
[TBL] [Abstract][Full Text] [Related]
8. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic transformations in vitro produced by misonidazole.
Miller RC; Hall EJ
Cancer Clin Trials; 1980; 3(1):85-90. PubMed ID: 7389040
[TBL] [Abstract][Full Text] [Related]
10. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
Saunders ME; Dische S; Anderson P; Flockhart IR
Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
[TBL] [Abstract][Full Text] [Related]
11. The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Coleman CN; Ballon SC; Howes AE; Martinez A; Halsey J; Hirst VK
Gynecol Oncol; 1984 May; 18(1):18-27. PubMed ID: 6201419
[TBL] [Abstract][Full Text] [Related]
12. The neurotoxicity of misonidazole: potential modifying role of dexamethasone.
Workman P
Br J Radiol; 1980 Jul; 53(631):736. PubMed ID: 7426903
[No Abstract] [Full Text] [Related]
13. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
Jones DH; Bleehen NM; Workman P; Smith NC
Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
[TBL] [Abstract][Full Text] [Related]
14. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
[TBL] [Abstract][Full Text] [Related]
15. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
Dische S; Saunders MI; Flockhart IR
Br J Cancer Suppl; 1978 Jun; 3():318-21. PubMed ID: 209811
[TBL] [Abstract][Full Text] [Related]
16. Misonidazole-a drug for trial in radiotherapy and oncology.
Dische S; Saunders MI; Flockhart IR; Lee ME; Anderson P
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):851-60. PubMed ID: 227822
[No Abstract] [Full Text] [Related]
17. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
Wasserman TH; Phillips TL; Johnson RJ; Gomer CJ; Lawrence GA; Sadee W; Marques RA; Levin VA; VanRaalte G
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):775-86. PubMed ID: 227821
[No Abstract] [Full Text] [Related]
18. The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.
Rose GP; Taylor JM
Toxicology; 1985 Jan; 34(1):43-56. PubMed ID: 3918357
[TBL] [Abstract][Full Text] [Related]
19. Misonidazole also radiosensitizes some normal tissue.
Arcangeli G; Nervi C; Mauro F
Br J Radiol; 1980 Jan; 53(625):44-5. PubMed ID: 6766338
[No Abstract] [Full Text] [Related]
20. Loss of hearing after misonidazole.
Abratt RP; Blackburn JD
Br J Radiol; 1980 Dec; 53(636):1208. PubMed ID: 7437740
[No Abstract] [Full Text] [Related]
[Next] [New Search]
